Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1437)	9/28/1998 5:56:00 PM
From: Steve Harmon	Respond to of 2742

Who knows????? Shareholders were told in a news release in July>>>That the PMC transaction is subject to the execution of definitive agreements on or before October 1, 1998... I guess the shareholders will know by then???

To: Walter Morton who wrote (1437)	9/29/1998 12:58:00 AM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

Cistron shareholders, The Bluestone Capital contract originally set for just six months and then extended another six months is due to expire on this Wednesday, Sept. 30. Actually the Bluestone contract was initially started on Sept. 5, 1997 so the financial advisor contract is really nearing 13 months. 13 months! WOW. Bluestone Capital is probably very happy that this long ordeal is finally over. The definitive deal with PMC if executed on or before October 1...will bring closure to the Bluestone deal and they can finally start to give Cistron some stock support.